MaxCyte, Inc.
NASDAQ:MXCT · NASDAQ Global Select
+$0.05 today
Vol 1.75M · Avg 0.95M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-44.24%
Period High
$2.33
Period Low
$0.68
Latest
$1.21
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$345.84M
Prenetics Global Limited
NASDAQ:PRE
$341.62M
Armata Pharmaceuticals, Inc.
AMEX:ARMP
$254.77M
Perspective Therapeutics, Inc.
AMEX:CATX
$231.36M
Profound Medical Corp.
NASDAQ:PROF
$204.95M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$149.37M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$118.65M
Owlet, Inc.
NYSE:OWLT
$91.47M
Sangamo Therapeutics, Inc.
NASDAQ:SGMO
$72.83M
LENSAR, Inc.
NASDAQ:LNSR
$69.12M
What is the latest MXCT filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does MXCT have?
Intrinsic Alpha currently shows 20 recent filings for MXCT.
Explore More
Continue the stock analysis
Jump to another research area for this company.